Is the Reported $400 Billion AstraZeneca-Bristol Myers Squibb Megamerger a Slam Dunk -- or a Disaster Waiting to Happen?

This is a summary. Read the complete story at Yahoo Finance below.

Related Stories

marketsabout 3 hours ago

Hollywood’s big debt deal hits a wall of higher yields as Paramount finances Warner Bros. buyout

The Paramount financing will be a closely watched barometer of dealmaking appetite despite rising borrowing costs in 2026.

MarketWatch

marketsabout 3 hours ago

Could SpaceX be worth $12 trillion one day? Citi says Starship gets it a step closer.

The recent Starship launch helps SpaceX with a number of priorities that could help its stock reach $900 over the long run, an analyst says.

MarketWatch

marketsabout 3 hours ago

The real prize in AMD’s $8 billion World Labs acquisition isn’t what you’d think

AMD is getting cutting-edge spatial-intelligence models, but more importantly, a leader who can help recruit top talent and bring real-world AI applications into focus.

MarketWatch